Alliance for Cancer Gene Therapy Seeks Applications for Young Investigator Award

Deadline: September 15, 2004

Alliance for Cancer Gene Therapy is requesting applications for its 2004 AGCT Young Investigator Award. The overall objectives of this grant are to advance gene therapy into the causes, treatment, and prevention of all types of cancer by promoting development of novel and innovative studies by young investigators. The emphasis of this initiative is to promote basic and pre-clinical research approaches utilizing cells and genes as medicine.

The program six main areas of research: tumor-specific replicating viruses and bacteria; anti- angiogenesis; immune-mediated gene therapy and cancer vaccines; oncogenes/suppressor and oncogenes/apoptosis; tumor targeting and vector development; and other cancer gene therapy research.

Eligibility
Candidates for a Young Investigator Award must hold an M.D., M.P.H., Ph.D., or equivalent degree and be a tenure-track Assistant Professor within five years of their initial appointment to this rank at the time of award activation. The investigator must be conducting original research as an independent faculty member. ACGT has no citizenship restrictions, and research supported by the award must be conducted at medical schools and research centers only in the United States.

Award Information
Each grant will be awarded up to $500,000 over a period of three to five years (inclusive of 10 percent indirect cost).

The complete Request for Applications can be downloaded at the AGCT Web site at http://acgtfoundation.org/research.html.

About The Organization
Alliance for Cancer Gene Therapy is a public charity that funds research aimed at furthering the development of gene therapy approaches to the treatment of cancer.